Vcanbio Cell & Gene Engineering Corp Ltd (600645) — Capital Reinvestment Ratio
Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a Capital Reinvestment Ratio of 0.13x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥103.70 Million) in capital expenditures (CN¥13.28 Million). See how leveraged is Vcanbio Cell & Gene Engineering Corp Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vcanbio Cell & Gene Engineering Corp Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Vcanbio Cell & Gene Engineering Corp Ltd's Capital Reinvestment Ratio across 25 annual periods. Check Vcanbio Cell & Gene Engineering Corp Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Vcanbio Cell & Gene Engineering Corp Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Vcanbio Cell & Gene Engineering Corp Ltd from 1999 to 2025. For live market cap and broader valuation context, see 600645 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥313.63 Million | CN¥49.56 Million | ▼ -33.1% |
| 2024 | 0.24x | CN¥285.19 Million | CN¥67.32 Million | ▼ -20.3% |
| 2023 | 0.30x | CN¥299.02 Million | CN¥88.61 Million | ▼ -21.8% |
| 2022 | 0.38x | CN¥261.89 Million | CN¥99.19 Million | ▼ -4.8% |
| 2021 | 0.40x | CN¥320.96 Million | CN¥127.74 Million | ▲ +6.0% |
| 2020 | 0.38x | CN¥244.35 Million | CN¥91.72 Million | ▼ -26.3% |
| 2019 | 0.51x | CN¥241.49 Million | CN¥122.95 Million | ▼ -48.3% |
| 2018 | 0.99x | CN¥130.08 Million | CN¥128.13 Million | ▼ -16.6% |
| 2017 | 1.18x | CN¥70.27 Million | CN¥83.02 Million | ▼ -37.1% |
| 2016 | 1.88x | CN¥143.67 Million | CN¥269.85 Million | ▼ -88.1% |
| 2015 | 15.74x | CN¥8.17 Million | CN¥128.70 Million | ▲ +5665.4% |
| 2014 | 0.27x | CN¥221.45 Million | CN¥60.47 Million | ▼ -57.1% |
| 2013 | 0.64x | CN¥110.72 Million | CN¥70.43 Million | ▼ -19.4% |
| 2012 | 0.79x | CN¥70.41 Million | CN¥55.56 Million | ▲ +488.4% |
| 2011 | 0.13x | CN¥110.44 Million | CN¥14.81 Million | ▲ +352.1% |
| 2010 | 0.03x | CN¥175.93 Million | CN¥5.22 Million | ▼ -78.6% |
| 2009 | 0.14x | CN¥124.92 Million | CN¥17.32 Million | ▼ -17.0% |
| 2008 | 0.17x | CN¥121.60 Million | CN¥20.32 Million | ▲ +4.1% |
| 2007 | 0.16x | CN¥111.68 Million | CN¥17.92 Million | ▼ -74.4% |
| 2006 | 0.63x | CN¥76.12 Million | CN¥47.67 Million | ▼ -7.8% |
| 2005 | 0.68x | CN¥84.69 Million | CN¥57.55 Million | ▲ +44.2% |
| 2004 | 0.47x | CN¥57.76 Million | CN¥27.23 Million | ▼ -45.5% |
| 2003 | 0.86x | CN¥41.74 Million | CN¥36.08 Million | ▲ +219.3% |
| 2000 | 0.27x | CN¥31.71 Million | CN¥8.58 Million | ▼ -87.2% |
| 1999 | 2.12x | CN¥4.13 Million | CN¥8.76 Million | — |